EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 175.00 billion. The enterprise value is 326.95 billion.
Market Cap | 175.00B |
Enterprise Value | 326.95B |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -0.83% in one year.
Current Share Class | 33.08M |
Shares Outstanding | 33.08M |
Shares Change (YoY) | -0.83% |
Shares Change (QoQ) | -2.27% |
Owned by Insiders (%) | 1.34% |
Owned by Institutions (%) | 0.33% |
Float | 16.05M |
Valuation Ratios
The trailing PE ratio is 9.14 and the forward PE ratio is 5.94.
PE Ratio | 9.14 |
Forward PE | 5.94 |
PS Ratio | 0.46 |
PB Ratio | 1.97 |
P/TBV Ratio | 9.77 |
P/FCF Ratio | 8.14 |
P/OCF Ratio | 6.79 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.20, with an EV/FCF ratio of 15.20.
EV / Earnings | 16.68 |
EV / Sales | 0.85 |
EV / EBITDA | 8.20 |
EV / EBIT | 10.09 |
EV / FCF | 15.20 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 2.36.
Current Ratio | 1.71 |
Quick Ratio | 0.82 |
Debt / Equity | 2.36 |
Debt / EBITDA | 5.25 |
Debt / FCF | 9.75 |
Interest Coverage | 3.59 |
Financial Efficiency
Return on equity (ROE) is 25.69% and return on invested capital (ROIC) is 9.06%.
Return on Equity (ROE) | 25.69% |
Return on Assets (ROA) | 7.61% |
Return on Invested Capital (ROIC) | 9.06% |
Return on Capital Employed (ROCE) | 13.95% |
Revenue Per Employee | 2.93B |
Profits Per Employee | 149.65M |
Employee Count | 131 |
Asset Turnover | 1.44 |
Inventory Turnover | 7.20 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.71% in the last 52 weeks. The beta is 0.93, so EASY BIO,Inc.'s price volatility has been similar to the market average.
Beta (5Y) | 0.93 |
52-Week Price Change | +26.71% |
50-Day Moving Average | 5,069.50 |
200-Day Moving Average | 4,373.53 |
Relative Strength Index (RSI) | 52.75 |
Average Volume (20 Days) | 225,549 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 384.33 billion and earned 19.60 billion in profits. Earnings per share was 579.00.
Revenue | 384.33B |
Gross Profit | 98.09B |
Operating Income | 32.39B |
Pretax Income | 26.38B |
Net Income | 19.60B |
EBITDA | 39.90B |
EBIT | 32.39B |
Earnings Per Share (EPS) | 579.00 |
Balance Sheet
The company has 62.50 billion in cash and 209.63 billion in debt, giving a net cash position of -147.12 billion or -4,447.24 per share.
Cash & Cash Equivalents | 62.50B |
Total Debt | 209.63B |
Net Cash | -147.12B |
Net Cash Per Share | -4,447.24 |
Equity (Book Value) | 88.80B |
Book Value Per Share | 2,538.27 |
Working Capital | 91.27B |
Cash Flow
In the last 12 months, operating cash flow was 25.76 billion and capital expenditures -4.25 billion, giving a free cash flow of 21.51 billion.
Operating Cash Flow | 25.76B |
Capital Expenditures | -4.25B |
Free Cash Flow | 21.51B |
FCF Per Share | 650.21 |
Margins
Gross margin is 25.52%, with operating and profit margins of 8.43% and 5.10%.
Gross Margin | 25.52% |
Operating Margin | 8.43% |
Pretax Margin | 6.86% |
Profit Margin | 5.10% |
EBITDA Margin | 10.38% |
EBIT Margin | 8.43% |
FCF Margin | 5.60% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.77%.
Dividend Per Share | 200.00 |
Dividend Yield | 3.77% |
Dividend Growth (YoY) | 100.00% |
Years of Dividend Growth | 2 |
Payout Ratio | 17.41% |
Buyback Yield | 0.83% |
Shareholder Yield | 4.59% |
Earnings Yield | 11.20% |
FCF Yield | 12.29% |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
Last Split Date | Dec 21, 2020 |
Split Type | Forward |
Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.2 |
Piotroski F-Score | n/a |